About
|
mobile Health AG was founded in 2014 by three highly experienced key opinion leaders in their field (Oncology, Healthcare Policy, Pharmaceutical Industry, Healthcare Insurance Industry). The founders are involved in product and business development and are dedicated to make Consilium Care™ a leading platform in Europe for PROs, bringing benefits to patients and treatment centers.
|
|
Our vision & mission
We improve the lives of people living with cancer through improved quality of care and treatment outcomes.
Through the collection of high-quality electronic patient-reported outcomes (ePRO) we continuously evolve our platform to enable stakeholders for improved quality of cancer care and significant reduction of treatment costs. The growing numbers of users and data allow us to develop analytic services (e.g. predictive algorithms) and patient self-care services.
Through the collection of high-quality electronic patient-reported outcomes (ePRO) we continuously evolve our platform to enable stakeholders for improved quality of cancer care and significant reduction of treatment costs. The growing numbers of users and data allow us to develop analytic services (e.g. predictive algorithms) and patient self-care services.
Team & expertise
|
Prof. Dr. med. Andreas Trojan
CEO & Chief Medical Officer & Founder Contact Andreas holds a position as senior oncologist at both, the Brust- and the OnkoZentrum Zürich in Switzerland. Moreover, he is a titular-professor at the medical faculty of the University of Zurich. Treating cancer patients over more than 20 years clearly indicated that the consideration of PROs is key for treatment success. Driven by this conviction Andreas founded Mobile Health AG and started to develop Consilium Care™, an App for patients to capture well-being and therapy side effects. Initially, Consilium Care™ has been used by breast cancer patients. The current large observational study, started in 2018, investigates the efficiency of the “Consilium Care™” smartphone App for detecting symptoms and treatment side effects in cancer patients depending on form of medication application, age and outpatient characteristics. |
|
Martin Rüfenacht
Sales & Marketing Contact Digital Health Evangelist with 20 years experience in Healthcare-ICT-Industry and in building eco-systems in government and healthcare. Martin is also board member IGeHealth & eCH. |
Bruno Odermatt
Chief Financial Officer
Contact
Bruno has more than 20 years experience in start up's as CFO (e.g. Prionics AG, HeiQ Materials AG). He is partner of Value Solutions Group, Former Head of Corporate Finance KPMG Switzerland and also Swiss Certified Public Accountant.
Chief Financial Officer
Contact
Bruno has more than 20 years experience in start up's as CFO (e.g. Prionics AG, HeiQ Materials AG). He is partner of Value Solutions Group, Former Head of Corporate Finance KPMG Switzerland and also Swiss Certified Public Accountant.
|
Mathis Brauchbar
Member VR, Founder Contact Mathis has an education in philosophy and molecular biology. With more than 20 years’ experience in health care and life sciences he consults hospital leaders, government agencies, industry and non-governmental organizations in policy and strategy development, public affairs as well as in stakeholder management. His consultancy activities allowed the set-up of a remarkable network of international key opinion leaders and experts of special fields. |
|
Nick Leuthold
med. pract. Clinical Evaluation & studies Contact Nick has Recently graduated in Human Medicine and is highly interested in the digital transformation processes currently happening in the medical world. He is currently writing his MD thesis at the University of Zurich on ePROs. |
|
|